Research Article

Related GMR Articles

Cervical cancer; Genotyping; Human papillomavirus; Prophylactic vaccines

Human papillomavirus (HPV) has been extensively studied concerning genomic structure, infection mechanisms, and diversity of types, as well as disease progression stages and development of vaccines. HPV type prevalence can differ in specific populations in different countries, according to ethnicity. This is the first report of an integrated project to evaluate the incidence of HPV types ... more

M.F.P.T.Baldez da Silva; B.S. Chagas; V. Guimarães; L.M.C. Katz; P.M. Felix; P.M. Miranda; A.A. Lima; L.C. Arraes; D.B.G. Martins; J.L.Lima Filho; R.C. Stocco; S. Crovella; A.C. Freitas; W. Beçak
Amazon region; Cervical cancer; HPV; PCR

Infection by human papillomavirus (HPV) is one of the primary causes of mortality by cancer in northern Brazil. Sexually active women from Manaus, Amazonas, without cytological alterations and women with pre-malignant and malignant cytological alterations were examined for HPV virus, identified via PCR and sequencing. The target region for this study was part of the L1 capsid gene of HPV ... more

M.M. Castro; I.P. Farias; C.M. Borborema-Santos; G. Correia; S. Astolfi-Filho
5-Aza-2´-deoxycytidine; APAF-1; Cervical cancer; DNA methylation; RASSF1A

The methylation of tumor suppressor genes has been shown to be involved in many human cancers. 5-Aza-2’-deoxycytidine (5-Aza-CdR) can reactivate the expression of methylated tumor suppressor genes. In our study, 2 human cervical cancer cell lines, HeLa and SiHa, were treated with different concentrations (20, 10, 5, and 2.5 μM) of 5-Aza-CdR for 24, 48, and 72 h. After incubation, cells ... more

T.T. Yao; S.M. Mo; L.Y. Liu; H.W. Lu; M.L. Huang; Z.Q. Lin
Amazon population; Cervical cancer; Human papillomavirus; Peru; Urban population

We made a study of the prevalence of human papillomavirus (HPV) and cervix lesions in an Amazonian Bora native population (Bn) and compared it with the prevalence in an urban population in Iquitos (Iq). We also examined the distribution of HPV types among abnormal cervical smears in the Iq population. Swabs and cytologies were collected from 472 females. DNA consensus PCR, followed by ... more

M. Martorell; J.A. Garcia-Garcia; D. Gomez-Cabrero; A. del Aguila
Cervical cancer; Cervical lesions; Human papillomavirus

Human papilloma virus (HPV) is a well-established cause of cervical cancer. While many studies have been performed so far on HPV viral biology, mode of infection and prevention measures, scanty information is available on lesion sites of infected women and the incidence of viral types at specific locations. We looked for a possible relationship between the most common viral types (HPVs 16 ... more

M.F.P.T.Baldez da Silva; V. Guimarães; M.A.R. Silva; C.M.Medeiros d Amaral; W. Beçak; R.C. Stocco; A.C. Freitas; S. Crovella
Cervical cancer; Radiosensitivity; RNA interference; SiHa cells; Vascular endothelial growth factor

This study aimed to investigate the inhibition of vascular endothelial growth factor (VEGF) by small hairpin RNA (shRNA) interference combined with radiotherapy on the growth of cervical cancer SiHa cell xenografts in nude mice. The effective pVEGF-shRNA plasmid was screened by reverse transcription-polymerase chain reaction (RT-PCR), and the cell apoptosis rate was estimated by flow ... more

L. Qi; L.N. Xing; X. Wei; S.G. Song
Cervical cancer; Gynecological laparoscopic operation; Ureteral catheter

The aim of this study was to evaluate the clinical efficacy of a temporary ureteral catheter in preventing iatrogenic ureteral damage in cervical cancer patients undergoing laparoscopic radical hysterectomy. All cases had confirmed diagnoses of cervical cancer preoperatively between December 2008 and December 2012 in our hospital and were in clinical stages IA2 to IIA. In total, 176 ... more

L. Han; R. Cao; J.Y. Jiang; Y. Xi; X.C. Li; G.H. Yu
Cell apoptosis; Cell cycle; Cell proliferation; Cervical cancer; Forkhead box protein 01; Immunohistochemistry

Forkhead box protein O1 (FOXO1) is an important transcriptional regulator of cell proliferation, and is considered essential for tumor growth and progression. However, the function of FOXO1 in human cervical cancer remains unclear. In this study, we investigated the role of FOXO1 in cervical cancer. Our results showed that FOXO1 expression was lower in cervical cancer than in cervical ... more

B. Zhang; L.S. Gui; X.L. Zhao; L.L. Zhu; Q.W. Li
BORIS; Cervical cancer; CTCF; Squamous intraepithelial lesions

We investigated the expression of Brother of Regulator of Imprinted Sites (BORIS) and CCCTC-binding factor (CTCF) in squamous intraepithelial lesions and cervical cancer. To analyze BORIS and CTCF expression, an endocervical cytobrush sample was taken for total RNA isolation. CTCF and BORIS mRNA was quantified from total RNA using ... more

N. Velázquez-Hernández; M.A. Reyes-Romero; M. Barragán-Hernández; F. Guerrero-Romero; M. Rodríguez-Moran; M. Aguilar-Duran; L. Medina
Cervical cancer; Ebp1 protein; Epidermal growth factor recepto

The objectives of this study were to observe the changes in expression of ErbB-3 binding protein (Ebp1) in cervical cancer and to investigate their clinic significance. We detected the expression level of Ebp1 in cancerous and adjacent tissues from 56 patients with cervical cancer. We identified 21 Ebp1 positive samples (37.5%) from among the 56 cervical cancer tissue samples and 5 Ebp1 ... more

L. Liu; D.Y. Xu; S.S. Yang; X.D. Li